New research from a Fred Hutch group led by Trang VoPham found there is a positive association between ambient PM2.5 exposure — a primary pollutant emitted in #wildfire smoke — and odds of nonalcoholic fatty liver disease among hospitalized patients. bit.ly/3gmlgAI

Join us as we partner with American Cancer Society for the Making Strides of Seattle, breast cancer initiative 5k walk. Help us raise lifesaving funds to support breast cancer patients, survivors, and caregivers through every step of the journey. More here: bit.ly/3yQuiwu

Researchers including Fred Hutch's McGuire Lab are speeding up efforts to develop a vaccine against the Epstein-Barr virus. Read more: cnn.com/2022/10/18/hea…

Studies have long linked Epstein-Barr virus to cancer & MS. Now, Moderna and NIAID News have launched separate clinical vaccine trials. EBV vaccines are in early testing at Opko Health; Fred Hutchinson Cancer Center; and City of Hope. cnn.com/2022/10/18/hea…

'You start a conversation, you can't even finish it
You're talking a lot, but you're not saying anything!' (Talking Heads, 1977) David Bacsik leads the Bloom Lab & shows highly-transcribed viruses (talking) *don't* produce the most progeny (saying anything)! tinyurl.com/yckhkcn8

Small cell lung cancer (SCLC) is often resistant to immunotherapies, but Joe Hiatt of the MacPherson lab shows that a tandem approach of bomedemstat and anti-PD1 treatments is more successful than either treatment alone. tinyurl.com/4vdn4j6w

Here is an updated plot showing the remarkable similarity in the patterns of where spike mutations occur in the #SARSCoV2 variant BQ.1.1 versus the long terms hotspots of evolutionary change in human CoV-229E.

Biomarker discovery for the early detection of esophageal adenocarcinoma and high-grade dysplasia
fredhutch.org/content/www/en… via Fred Hutchinson Cancer Center

#esophagealcancer #esophagealcancer awareness #cancer #cancer research #research Esophageal Cancer

In new work published in Science Immunology, Drs. Simone Minnie and Geoff Hill show that by directing immune stimulation at the right group of cells, they can prevent #leukemia and #myeloma relapse after #bonemarrowtransplant without exacerbating #GVHD . bit.ly/3TnBTuh

At age 33, Teresa Campagna learned that she carries two mutations that put her at higher risk of developing #breastcancer . She found that Fred Hutch’s Breast Cancer Specialty Clinic and its multidisciplinary team approach was the right fit for her. #BCAM bit.ly/3RKVi75

Congrats, Ana Mari Cauce, on this well-deserved honor! National Academy of Medicine UW Medicine

After 2 years and 48 (!!) articles, my time as the Basic Sciences editor for #ScienceSpotlight Fred Hutchinson Cancer Center Hutch Basic Sciences has come to a close. I've loved being so engrossed in the division's work. Check out my last 2 pieces, out today:

'A 20% reduction in cancer is still a successful test. A 50% reduction is excellent,' said Fred Hutch's Dr. Ruth Etzioni. 'Colonoscopy works as a test, but in the end we probably just need an easier test that people will actually do. That’s the take-home.'bit.ly/3ga8ncY

Check our more of our latest student blogs from the Pathways Research Explorers program! bit.ly/3xJAENH Fred Hutchinson Cancer Center National Cancer Institute

Tweetorial as promised: Excited to share our work from the Hill Lab published in collaboration with Scott Furlan and Aaron Ring (among many others from qimrberghofer Monash University Yale University Fred Hutchinson Cancer Center). See paper here: science.org/doi/10.1126/sc…. 🧵on what we found below!

In new work published in Science Immunology, Drs. Simone Minnie and Geoff Hill show that by directing immune stimulation at the right group of cells, they can prevent #leukemia and #myeloma relapse after #bonemarrowtransplant without exacerbating #GVHD . bit.ly/3TnBTuh

Computational biologist Dr. Anat Zimmer, a post-doctoral researcher in Dr. Gavin Ha's lab at Fred Hutchinson Cancer Center, was awarded a 2022-23 fellowship by the American Association of University Women, or AAUW. bit.ly/3CVOJdV

Cancer diagnostics are in a revolutionary growth phase, according to biostatistician Dr. Ruth Etzioni. The longtime Fred Hutch researcher just received a $7.4 million grant to create tools and frameworks to evaluate these tests and how they're used. bit.ly/3rHyLh3